Ellen de Brabander - 01 Mar 2022 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President of Innovation and Regulatory Affairs
Signature
/s/ Collin Smyser, Attorney-in-Fact for Ellen de Brabander
Issuer symbol
ELAN
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 19:58:45 UTC
Previous filing
08 Nov 2021
Next filing
03 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +14,496 +32% $0.000000 60,131 01 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +38,522 $0.000000 38,522 01 Mar 2022 Common Stock 38,522 $28.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
F2 Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.

Remarks:

Executive Vice President of Innovation and Regulatory Affairs